deltatrials
Completed NA NCT00013871

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions HIV Infections Hepatitis B Measles Pertussis Pneumococcal Infections
Interventions Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed Hepatitis B Vaccine (Recombinant) Measles-Mumps-Rubella Vaccine (Live) Pneumococcal Conjugate Vaccine, Heptavalent Pneumococcal Vaccine, Polyvalent (23-valent)
Updated 7 times since 2017 Last updated: Oct 28, 2021 Completion: Nov 30, 2004

Listed as NCT00013871, this NA trial focuses on HIV Infections and Hepatitis B and remains completed. Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), it has been updated 7 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Dec 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2021 — Dec 2021 [monthly]

    Completed NA

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  2. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aurora, United States, Baltimore, United States, Birmingham, United States, Boston, United States, Brooklyn, United States, Chicago, United States, Columbus, United States, Fort Lauderdale, United States, Gainesville, United States, Hartford, United States and 20 more location s